EUVIMEDEUVIMED entdecken
FallberichtVideo/Audio

Use of peroral cholangiopancreatoscopy-assisted endoscopic mucosal resection for biliopancreatic intraductal lesions

Wengang Zhang, Yaqi Zhai iD, Bozong Shao, Jiafeng Wang, Qingzhen Wu, Ningli Chai, Enqiang Linghu iD

Endoscopy · 01.03.2025 · 57 (03) · 255-261

DOI: 10.1055/a-2387-9170 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endoscopy, erschienen am 01.03.2025. Verfasst von Wengang Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Endoscopy, Digestive System, Natural Orifice Endoscopic Surgery, Pancreatic Intraductal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Chinese PLA General Hospital Young Independent Innovation Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to assess the feasibility and safety of performing cholangiopancreatoscopy-assisted endoscopic mucosal resection (CA-EMR) for biliopancreatic intraductal lesions.

Methods

Special electrocautery snares and injection needles that can pass through the working channel of a single-operator cholangiopancreatoscope were developed. Between November 2023 and April 2024, we performed CA-EMR for two patients with gallbladder polyps, one patient with a neoplastic lesion in the common bile duct (CBD), and one patient with a neoplastic lesion in the main pancreatic duct. The technical success rate and adverse events were recorded.

Results

All four CA-EMR procedures were performed successfully. Postoperative pathology revealed inflammatory gallbladder polyps in two patients, low grade intraepithelial neoplasia of the CBD in one patient, and intraductal papillary mucinous neoplasm (IPMN) in one patient. The patient with IPMN experienced mild postoperative pancreatitis and recovered after conservative treatment. No adverse events were encountered in the other three CA-EMR procedures.

Conclusion

This study preliminarily confirmed the feasibility and safety of CA-EMR for treating biliopancreatic intraductal lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionEndoscopy, Digestive SystemNatural Orifice Endoscopic SurgeryPancreatic Intraductal NeoplasmsPolypsHumansCommon Bile DuctFeasibility Studies

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Yaqi Zhai, Enqiang Linghu

Förderung

  • Chinese PLA General Hospital Young Independent Innovation Science Fund

Zitieren

APA

Zhang, W., Zhai, Y., Shao, B., Wang, J., Wu, Q., Chai, N., & Linghu, E. (2025). Use of peroral cholangiopancreatoscopy-assisted endoscopic mucosal resection for biliopancreatic intraductal lesions. Endoscopy, 57(03), 255-261. https://doi.org/10.1055/a-2387-9170

Vancouver

Zhang W, Zhai Y, Shao B, Wang J, Wu Q, Chai N, et al. Use of peroral cholangiopancreatoscopy-assisted endoscopic mucosal resection for biliopancreatic intraductal lesions. Endoscopy. 2025;57(03):255-261. doi:10.1055/a-2387-9170

BibTeX
@article{Zhang2025,
  author = {Zhang, Wengang and Zhai, Yaqi and Shao, Bozong and Wang, Jiafeng and Wu, Qingzhen and Chai, Ningli and Linghu, Enqiang},
  title = {Use of peroral cholangiopancreatoscopy-assisted endoscopic mucosal resection for biliopancreatic intraductal lesions},
  journal = {Endoscopy},
  year = {2025},
  volume = {57},
  number = {03},
  pages = {255--261},
  doi = {10.1055/a-2387-9170}
}
Kostenlos starten →